wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38371340-F3532CA0-6DAA-4C90-9286-D914357B5692
Q38371340-F3532CA0-6DAA-4C90-9286-D914357B5692
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371340-F3532CA0-6DAA-4C90-9286-D914357B5692
Patient-reported outcomes as end points and outcome indicators in solid tumours.
P2860
Q38371340-F3532CA0-6DAA-4C90-9286-D914357B5692
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371340-F3532CA0-6DAA-4C90-9286-D914357B5692
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f6341e7321f19a6db9c9c0c49cab9ce74e40fd19
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.